stocktools
Offerings // ADC Therapeutics SA

ADCT offering history

Every offering-related filing in ADC Therapeutics SA’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 440 filings back to Jun 27, 2019.

Last executed offering
Oct 13, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Mar 10, 2026
S-3 — capacity, not a sale
Executed, last 12 months
2
424B pricings + 8-K 3.02 sales
Registered, last 12 months
3
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 13, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 15, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 16, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 16, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 10, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 23, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 12, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 12, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 9, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Nov 10, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Oct 14, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 10, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 9, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 30, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 12, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 13, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 6, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 7, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 6, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 14, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 14, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 14, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 24, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 20, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 15, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Feb 2, 2023FWP →MARKETINGFree-writing prospectus — offering being marketed
Feb 2, 2023FWP →MARKETINGFree-writing prospectus — offering being marketed
Feb 2, 2023424B7 →UPDATEResale prospectus — existing holders registering to sell
Sep 16, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 16, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 16, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 16, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 6, 2022F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Sep 6, 2022F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jun 4, 2021F-3ASR →REGISTEREDAutomatic shelf registration — effective immediately (large filers)
Jun 1, 2021F-3ASR →REGISTEREDAutomatic shelf registration — effective immediately (large filers)
Sep 25, 2020424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 23, 2020EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
ADCT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ADCT workspace →
ADCT offering FAQ

When did ADCT last execute an offering?

Per SEC filings, ADC Therapeutics SA's most recent priced offering document is a 8-K filed 2026-10-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ADCT last announce or register an offering?

The most recent registration is a S-3 filed 2026-03-10. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.